Home NDC 49702-243 NDC 49702-243 - Cabenuva This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 49702-243
Package NDCs from labels 49702-243-02, 49702-243-61
Manufacturer ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV
Effective date 2025-11-26
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 49702-243-02 Cabenuva 3 mL in 1 VIAL INJECTION, SUSPENSION, EXTENDED 1 mL 300 mg in 1mL 16 49702-243-61 Cabenuva 3 mL in 1 VIAL INJECTION, SUSPENSION, EXTENDED 1 mL 300 mg in 1mL 16
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 49702-243 CABENUVA (CABOTEGRAVIR AND RILPIVIRINE) KIT [VIIV HEALTHCARE COMPANY] 14 Unmatched 20250416_1698baf3-f895-4c42-a1b1-e9ee3f20da36.zip